PMID- 16843639 OWN - NLM STAT- MEDLINE DCOM- 20070410 LR - 20131121 IS - 0898-6568 (Print) IS - 0898-6568 (Linking) VI - 19 IP - 1 DP - 2007 Jan TI - Signalling through phospholipase C interferes with clathrin-mediated endocytosis. PG - 42-51 AB - We investigated if phosphatidylinositol(4,5)bisphosphate (PtdIns(4,5)P2) hydrolysis by phospholipase C activation through cell surface receptors would interfere with clathrin-mediated endocytosis as recruitment of clathrin assembly proteins is PtdIns(4,5)P2-dependent. In the WKPT renal epithelial cell line, endocytosed insulin and beta2-glycoprotein I (beta2gpI) were observed in separate compartments, although endocytosis of both ligands was clathrin-dependent as demonstrated by expression of the clathrin-binding C-terminal domain of AP180 (AP180-C). The two uptake mechanisms were different as only insulin uptake was reduced when the mu2-subunit of the adaptor complex AP-2 was silenced by RNA interference. ATP receptors are expressed at the apical surface of renal cells and, thus, we examined the effect of extracellular ATP on insulin and beta2gpI uptake. ATP stimulated phospholipase C activity, and also suppressed uptake of insulin, but not beta2gpI. This effect was reversed by the PLC inhibitor U-73122. In polarized cell cultures, insulin uptake was apical, whereas beta2gpI uptake was through the basolateral membrane, thus providing an explanation for selective inhibition of insulin endocytosis by ATP. Taken together, these results demonstrate that stimulation of apical G-protein-coupled P2Y receptors, which are coupled to phospholipase C activation diminishes clathrin-mediated endocytosis without interfering with basolateral endocytic mechanisms. FAU - Carvou, Nicolas AU - Carvou N AD - Department of Physiology, University College London, London WC1E 6JJ UK. FAU - Norden, Anthony G W AU - Norden AG FAU - Unwin, Robert J AU - Unwin RJ FAU - Cockcroft, Shamshad AU - Cockcroft S LA - eng GR - Wellcome Trust/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20060606 PL - England TA - Cell Signal JT - Cellular signalling JID - 8904683 RN - 0 (Clathrin) RN - 0 (Estrenes) RN - 0 (Insulin) RN - 0 (Monomeric Clathrin Assembly Proteins) RN - 0 (Pyrrolidinones) RN - 0 (Receptors, Purinergic P2) RN - 0 (Transcription Factor AP-2) RN - 0 (beta 2-Glycoprotein I) RN - 0 (clathrin assembly protein AP180) RN - 112648-68-7 (1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione) RN - 8L70Q75FXE (Adenosine Triphosphate) RN - EC 2.7.1.- (Phosphotransferases (Alcohol Group Acceptor)) RN - EC 2.7.1.- (phosphatidylinositol 4,5-biphosphate kinase) RN - EC 3.1.4.- (Type C Phospholipases) SB - IM MH - Adenosine Triphosphate/metabolism MH - Animals MH - Cell Line MH - Clathrin/*physiology MH - *Endocytosis MH - Enzyme Activation MH - Epithelial Cells/physiology MH - Estrenes/pharmacology MH - Insulin/metabolism MH - Monomeric Clathrin Assembly Proteins/metabolism MH - Phosphotransferases (Alcohol Group Acceptor)/metabolism MH - Protein Structure, Tertiary MH - Pyrrolidinones/pharmacology MH - Rats MH - Receptors, Purinergic P2/metabolism MH - Signal Transduction MH - Transcription Factor AP-2/metabolism MH - Type C Phospholipases/antagonists & inhibitors/*physiology MH - Urothelium/cytology MH - beta 2-Glycoprotein I/metabolism EDAT- 2006/07/18 09:00 MHDA- 2007/04/11 09:00 CRDT- 2006/07/18 09:00 PHST- 2006/02/03 00:00 [received] PHST- 2006/05/23 00:00 [revised] PHST- 2006/05/24 00:00 [accepted] PHST- 2006/07/18 09:00 [pubmed] PHST- 2007/04/11 09:00 [medline] PHST- 2006/07/18 09:00 [entrez] AID - S0898-6568(06)00133-1 [pii] AID - 10.1016/j.cellsig.2006.05.023 [doi] PST - ppublish SO - Cell Signal. 2007 Jan;19(1):42-51. doi: 10.1016/j.cellsig.2006.05.023. Epub 2006 Jun 6.